Pfizer Inc (PFE)

PFE on New York Consolidated

34.17USD
26 May 2015
Change (% chg)

$-0.11 (-0.32%)
Prev Close
$34.28
Open
$34.18
Day's High
$34.34
Day's Low
$34.10
Volume
6,192,416
Avg. Vol
26,189,266
52-wk High
$35.53
52-wk Low
$27.51

PFE

Chart for PFE

About

Pfizer Inc. is a bio pharmaceutical company. The company applies science and resources to discover, develop and manufacture healthcare products. The Company provides medicines, vaccines and consumer healthcare products. The Company operates its business through three operating segments, which include Global Innovative Pharmaceut... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $211,084.91
Shares Outstanding(Mil.): 6,157.67
Dividend: 0.28
Yield (%): 3.27

Financials

  PFE Industry Sector
P/E (TTM): 23.71 37.10 39.11
EPS (TTM): 1.45 -- --
ROI: 6.44 16.22 15.56
ROE: 12.69 16.99 16.57
Search Stocks

Roche drug shrinks tumors in half of patients with lung cancer mutation

- A drug being developed by Roche Holding AG was shown in pivotal trials to shrink tumors in patients with advanced lung cancer with a specific gene mutation who had stopped responding to crizotinib, another drug in the same class.

13 May 2015

Business groups say ADA doesn't entitle blind Pfizer worker to driver

- Three major business groups have asked a U.S. appeals court to uphold the dismissal of a former Pfizer Inc sales representative's suit claiming the pharmaceutical giant violated federal law by refusing to provide her with a full-time driver when she became legally blind.

13 May 2015

Mylan chairman said to consider Perrigo sweeteners to make deal: Bloomberg

- Mylan NV's Chairman Robert Coury said he may sweeten the company's offer for Perrigo Co Plc by adding terms that will reduce risk to Perrigo's shareholders, sources told Bloomberg on Monday.

11 May 2015

Mylan chairman said to consider Perrigo sweeteners to make deal -Bloomberg

May 11 - Mylan NV's Chairman Robert Coury said he may sweeten the company's offer for Perrigo Co Plc by adding terms that will reduce risk to Perrigo's shareholders, sources told Bloomberg on Monday.

11 May 2015

The new U.S. office politics: funding your boss's political causes

NEW YORK - It wasn’t long ago that politics, like religious affiliation or sexual orientation, was a taboo topic in the American workplace. Political beliefs were considered a private affair - off limits to the boss.

11 May 2015

INSIGHT-The new US office politics: funding your boss's political causes

NEW YORK, May 11 - It wasn't long ago that politics, like religious affiliation or sexual orientation, was a taboo topic in the American workplace. Political beliefs were considered a private affair - off limits to the boss.

11 May 2015

RPT-INSIGHT-The new US office politics: funding your boss's political causes

NEW YORK, May 11 - It wasn't long ago that politics, like religious orientation or sexual preference, was a taboo topic in the American workplace. Political beliefs were considered a private affair - off limits to the boss.

11 May 2015

INSIGHT-The new US office politics: funding your boss's political causes

NEW YORK, May 11 - It wasn't long ago that politics, like religious orientation or sexual preference, was a taboo topic in the American workplace. Political beliefs were considered a private affair - off limits to the boss.

11 May 2015

Factbox: Testing 'safety switches' for CAR T cancer therapies

NEW YORK - Drugmakers are building safety "switches" that can be used to turn off powerful cancer therapies known as CAR T cells when they cause life-threatening inflammation or attack healthy tissue. Conversely, they can be used to boost activity of the engineered T cells against tough solid tumors.

07 May 2015

Zoetis to cut up to 2,500 jobs, shut storage units

- Animal health products maker Zoetis Inc said it plans to cut up to a quarter of its workforce and exit nearly 40 percent of its manufacturing plants in its first major restructuring since being spun off from Pfizer Inc two years ago.

05 May 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $101.04 -0.31
Novartis AG (NOVN.VX) CHF96.80 -1.30
Merck & Co., Inc. (MRK.N) $59.00 -0.38
Roche Holding Ltd. (ROG.VX) CHF275.50 -2.40
Abbott Laboratories (ABT.N) $48.70 -0.33
Bayer AG (BAYGn.DE) €134.15 -2.95
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €90.40 -0.93
AstraZeneca plc (AZN.L) 4,375.79p -107.00
GlaxoSmithKline plc (GSK.L) 1,427.47p -37.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$1,000.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks